European Commission 30 January 2025, Commission Implementing Regulation (EU) 2025/163 of 30 January 2025 amending Implementing Regulation (EU) 2021/17 establishing a list of variations not requiring assessment in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council
Also known as
European Union · · · Cited by 5 · 30-01-2025
Official Journal
of the European Union
EN
L series
2025/163
31.1.2025
COMMISSION IMPLEMENTING REGULATION (EU) 2025/163
of 30 January 2025
amending Implementing Regulation (EU) 2021/17 establishing a list of variations not requiring assessment in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (1), and in particular Article 60(1) thereof,
Whereas:
(1)
On 8 January 2021 the Commission, as required under Article 60(1) of Regulation (EU) 2019/6 and taking into account the criteria listed in Article 60(2) of that Regulation, adopted Commission Implementing Regulation (EU) 2021/17 (2) establishing a list of variations not requiring assessment in accordance with Regulation (EU) 2019/6.
(2)
The European Medicines Agency and the Coordination Group on Veterinary Medicinal Products advised the Commission to update the Annex to Implementing Regulation (EU) 2021/17, based upon experience gained and evolving scientifical and technical knowledge.
(3)
Commission Delegated Regulation (EU) 2024/1159 (3) lays down rules on appropriate measures to ensure the effective and safe use of veterinary medicinal products authorised and prescribed for oral administration via routes other than medicated feed and administered by the animal keeper to food-producing animals. The product information on veterinary medicinal products authorised before the date of application of that Delegated Regulation are to be adapted if necessary with the requirements of Article 9, paragraphs 1 and 2 of that Delegated Regulation, and therefore a change to the terms of the marketing authorisation may be required.
Read the full text
This document is published by eur-lex.europa.eu.
Moonlit adds the citation network (5 references), article-level links and cross-references, which are available to search for free.
Sign in to Moonlit